A citation-based method for searching scientific literature

Gregory D Cuny, Natalia P Ulyanova, Debasis Patnaik, Ji-Feng Liu, Xiangjie Lin, Ken Auerbach, Soumya S Ray, Jun Xian, Marcie A Glicksman, Ross L Stein, Jonathan M G Higgins. Bioorg Med Chem Lett 2012
Times Cited: 46







List of co-cited articles
468 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.
Yasushi Ogawa, Yosuke Nonaka, Toshiyasu Goto, Eriko Ohnishi, Toshiyuki Hiramatsu, Isao Kii, Miyo Yoshida, Teikichi Ikura, Hiroshi Onogi, Hiroshi Shibuya,[...]. Nat Commun 2010
176
32

The selectivity of protein kinase inhibitors: a further update.
Jenny Bain, Lorna Plater, Matt Elliott, Natalia Shpiro, C James Hastie, Hilary McLauchlan, Iva Klevernic, J Simon C Arthur, Dario R Alessi, Philip Cohen. Biochem J 2007
30

Towards Gram-positive antivirulence drugs: new inhibitors of Streptococcus agalactiae Stk1.
Mayalen Oxoby, François Moreau, Lionel Durant, Alexis Denis, Jean-Marie Genevard, Vanida Vongsouthi, Sonia Escaich, Vincent Gerusz. Bioorg Med Chem Lett 2010
39
35


Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin.
D Huertas, M Soler, J Moreto, A Villanueva, A Martinez, A Vidal, M Charlton, D Moffat, S Patel, J McDermott,[...]. Oncogene 2012
72
28

Structure-activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors.
Gregory D Cuny, Maxime Robin, Natalia P Ulyanova, Debasis Patnaik, Valerie Pique, Gilles Casano, Ji-Feng Liu, Xiangjie Lin, Jun Xian, Marcie A Glicksman,[...]. Bioorg Med Chem Lett 2010
28
42

Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation.
Nora Göckler, Guillermo Jofre, Chrisovalantis Papadopoulos, Ulf Soppa, Francisco J Tejedor, Walter Becker. FEBS J 2009
166
23

Regulation of mitotic chromosome cohesion by Haspin and Aurora B.
Jun Dai, Beth A Sullivan, Jonathan M G Higgins. Dev Cell 2006
169
23

Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.
Tania Tahtouh, Jonathan M Elkins, Panagis Filippakopoulos, Meera Soundararajan, Guillaume Burgy, Emilie Durieu, Claude Cochet, Ralf S Schmid, Donald C Lo, Florent Delhommel,[...]. J Med Chem 2012
137
21

The role of DYRK1A in neurodegenerative diseases.
Jerzy Wegiel, Cheng-Xin Gong, Yu-Wen Hwang. FEBS J 2011
166
21

Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis.
Fangwei Wang, Jun Dai, John R Daum, Ewa Niedzialkowska, Budhaditya Banerjee, P Todd Stukenberg, Gary J Gorbsky, Jonathan M G Higgins. Science 2010
326
19

A small-molecule inhibitor of Haspin alters the kinetochore functions of Aurora B.
Anna De Antoni, Stefano Maffini, Stefan Knapp, Andrea Musacchio, Stefano Santaguida. J Cell Biol 2012
74
19

Structure and functional characterization of the atypical human kinase haspin.
Jeyanthy Eswaran, Debasis Patnaik, Panagis Filippakopoulos, Fangwei Wang, Ross L Stein, James W Murray, Jonathan M G Higgins, Stefan Knapp. Proc Natl Acad Sci U S A 2009
109
19


Activation, regulation, and inhibition of DYRK1A.
Walter Becker, Wolfgang Sippl. FEBS J 2011
138
17


Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B.
Alexander E Kelly, Cristina Ghenoiu, John Z Xue, Christian Zierhut, Hiroshi Kimura, Hironori Funabiki. Science 2010
347
17

A general framework for inhibitor resistance in protein kinases.
Deborah Balzano, Stefano Santaguida, Andrea Musacchio, Fabrizio Villa. Chem Biol 2011
42
19

Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation.
Fangwei Wang, Natalia P Ulyanova, John R Daum, Debasis Patnaik, Anna V Kateneva, Gary J Gorbsky, Jonathan M G Higgins. J Cell Biol 2012
77
17


DYRK1A: a potential drug target for multiple Down syndrome neuropathologies.
Walter Becker, Ulf Soppa, Francisco J Tejedor. CNS Neurol Disord Drug Targets 2014
66
17

A positive feedback loop involving Haspin and Aurora B promotes CPC accumulation at centromeres in mitosis.
Fangwei Wang, Natalia P Ulyanova, Maike S van der Waal, Debasis Patnaik, Susanne M A Lens, Jonathan M G Higgins. Curr Biol 2011
119
15

beta-Carboline alkaloids: biochemical and pharmacological functions.
Rihui Cao, Wenlie Peng, Zihou Wang, Anlong Xu. Curr Med Chem 2007
354
15

Modulation of the chromatin phosphoproteome by the Haspin protein kinase.
Alessio Maiolica, Maria de Medina-Redondo, Erwin M Schoof, Apirat Chaikuad, Fabrizio Villa, Marco Gatti, Siva Jeganathan, Hua Jane Lou, Karel Novy, Simon Hauri,[...]. Mol Cell Proteomics 2014
32
21

MNB/DYRK1A as a multiple regulator of neuronal development.
Francisco J Tejedor, Barbara Hämmerle. FEBS J 2011
144
15

A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.
Séverine Coutadeur, Hélène Benyamine, Laurence Delalonde, Catherine de Oliveira, Bertrand Leblond, Alicia Foucourt, Thierry Besson, Anne-Sophie Casagrande, Thierry Taverne, Angélique Girard,[...]. J Neurochem 2015
76
15

β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites.
Danielle Frost, Bessie Meechoovet, Tong Wang, Stephen Gately, Marco Giorgetti, Irina Shcherbakova, Travis Dunckley. PLoS One 2011
105
13


Two histone marks establish the inner centromere and chromosome bi-orientation.
Yuya Yamagishi, Takashi Honda, Yuji Tanno, Yoshinori Watanabe. Science 2010
331
13

Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
Mansour Debdab, François Carreaux, Steven Renault, Meera Soundararajan, Oleg Fedorov, Panagis Filippakopoulos, Olivier Lozach, Lucie Babault, Tania Tahtouh, Blandine Baratte,[...]. J Med Chem 2011
96
13

A review on medicinal importance, pharmacological activity and bioanalytical aspects of beta-carboline alkaloid ''Harmine''.
K Patel, M Gadewar, R Tripathi, S K Prasad, Dinesh Kumar Patel. Asian Pac J Trop Biomed 2012
98
13

Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.
Buxi Shi, Rihui Cao, Wenxi Fan, Liang Guo, Qin Ma, Xuemei Chen, Guoxian Zhang, Liqin Qiu, Huacan Song. Eur J Med Chem 2013
33
18

Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.
Rihui Cao, Wenxi Fan, Liang Guo, Qin Ma, Guoxian Zhang, Jianru Li, Xuemei Chen, Zhenghua Ren, Liqin Qiu. Eur J Med Chem 2013
37
16

10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A.
Hannes Falke, Apirat Chaikuad, Anja Becker, Nadège Loaëc, Olivier Lozach, Samira Abu Jhaisha, Walter Becker, Peter G Jones, Lutz Preu, Knut Baumann,[...]. J Med Chem 2015
55
13


Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4.
Christian Schmitt, Parisa Miralinaghi, Marica Mariano, Rolf W Hartmann, Matthias Engel. ACS Med Chem Lett 2014
35
17



Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors.
Katharina Rüben, Anne Wurzlbauer, Agnes Walte, Wolfgang Sippl, Franz Bracher, Walter Becker. PLoS One 2015
35
17



Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.
Meera Soundararajan, Annette K Roos, Pavel Savitsky, Panagis Filippakopoulos, Arminja N Kettenbach, Jesper V Olsen, Scott A Gerber, Jeyanthy Eswaran, Stefan Knapp, Jonathan M Elkins. Structure 2013
95
13


Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.
J Reniers, S Robert, R Frederick, B Masereel, S Vincent, J Wouters. Bioorg Med Chem 2011
59
10

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Oleg Fedorov, Brian Marsden, Vanda Pogacic, Peter Rellos, Susanne Müller, Alex N Bullock, Juerg Schwaller, Michael Sundström, Stefan Knapp. Proc Natl Acad Sci U S A 2007
266
10

Identification and characterization of a haploid germ cell-specific nuclear protein kinase (Haspin) in spermatid nuclei and its effects on somatic cells.
H Tanaka, Y Yoshimura, M Nozaki, K Yomogida, J Tsuchida, Y Tosaka, T Habu, T Nakanishi, M Okada, H Nojima,[...]. J Biol Chem 1999
86
10

Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization.
Fabrizio Villa, Paola Capasso, Marcello Tortorici, Federico Forneris, Ario de Marco, Andrea Mattevi, Andrea Musacchio. Proc Natl Acad Sci U S A 2009
45
11

Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Shikha S Chauhan, Anup K Singh, Sanjeev Meena, Minaxi Lohani, Akhilesh Singh, Rakesh K Arya, Srikanth H Cheruvu, Jayanta Sarkar, Jiaur R Gayen, Dipak Datta,[...]. Bioorg Med Chem Lett 2014
36
13

Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
Ming Zhao, Lanrong Bi, Wei Wang, Chao Wang, Michèle Baudy-Floc'h, Jingfang Ju, Shiqi Peng. Bioorg Med Chem 2006
72
10

Structure-activity relationship in the antitumor activity of 6-, 8- or 6,8-substituted 3-benzylamino-β-carboline derivatives.
Reiko Ikeda, Takanori Kimura, Tatsuya Tsutsumi, Syunsuke Tamura, Norio Sakai, Takeo Konakahara. Bioorg Med Chem Lett 2012
22
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.